Location: Del Mar, CA
CIK: 0001993440 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 7, 2024
Total Value: $632M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 359,114 | $36.74M | 5.8% | $68.62 | +20.9% | COM | 670703107 |
| ARGX | ARGENX SE | 54,440 | $29.51M | 4.7% | $380.43 | — | SPONSORED ADR | 04016X101 |
| INSM | INSMED INC | 356,451 | $26.02M | 4.1% | $42.03 | +75.6% | COM PAR $.01 | 457669307 |
| MIRM | MIRUM PHARMACEUTICALS INC | 647,611 | $25.26M | 4.0% | $29.91 | +33.4% | COM | 604749101 |
| PCVX | VAXCYTE INC | 211,985 | $24.22M | 3.8% | $51.94 | +73.5% | COM | 92243G108 |
| AXSM | AXSOME THERAPEUTICS INC | 255,294 | $22.94M | 3.6% | $69.19 | +26.2% | COM | 05464T104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,187,165 | $22.85M | 3.6% | $20.80 | -0.7% | COM | 87164F105 |
| ASND | ASCENDIS PHARMA A/S | 150,593 | $22.49M | 3.6% | $127.91 | — | SPONSORED ADR | 04351P101 |
| NTRA | NATERA INC | 155,650 | $19.76M | 3.1% | $114.81 | 0.0% | COM | 632307104 |
| — | INTRA-CELLULAR THERAPIES INC | 254,800 | $18.64M | 3.0% | $70.35 | — | COM | 46116X101 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 353,376 | $18.06M | 2.9% | $46.18 | +11.7% | COM | 22663K107 |
| TMDX | TRANSMEDICS GROUP INC | 114,247 | $17.94M | 2.8% | $60.33 | +155.4% | COM | 89377M109 |
| ACLX | ARCELLX INC | 214,298 | $17.9M | 2.8% | $66.59 | 0.0% | COMMON STOCK | 03940C100 |
| — | BLUEPRINT MEDICINES CORP | 178,929 | $16.55M | 2.6% | $107.78 | — | COM | 09627Y109 |
| — | VERONA PHARMA PLC | 572,928 | $16.48M | 2.6% | $28.77 | — | SPONSORED ADS | 925050106 |
| VRTX | VERTEX PHARMACEUTICALS INC | 35,222 | $16.38M | 2.6% | $369.42 | +30.0% | COM | 92532F100 |
| BHVN | BIOHAVEN LTD | 315,816 | $15.78M | 2.5% | $31.10 | +25.1% | COM | G1110E107 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 357,003 | $15.45M | 2.4% | $50.73 | -14.3% | COM | G31249108 |
| — | MERUS N V | 308,014 | $15.39M | 2.4% | $59.17 | — | COM | N5749R100 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,451,037 | $14.87M | 2.4% | $11.07 | -10.7% | COM | 68622P109 |
| ISRG | INTUITIVE SURGICAL INC | 30,254 | $14.86M | 2.4% | $398.28 | +16.9% | COM NEW | 46120E602 |
| HROW | HARROW INC | 326,582 | $14.68M | 2.3% | $33.81 | 0.0% | COM | 415858109 |
| VERA | VERA THERAPEUTICS INC | 326,494 | $14.43M | 2.3% | $37.61 | +0.9% | CL A | 92337R101 |
| BCAX | BICARA THERAPEUTICS INC | 562,391 | $14.32M | 2.3% | $25.50 | 0.0% | COM | 055477103 |
| GERN | GERON CORP | 3,124,967 | $14.19M | 2.2% | $4.55 | 0.0% | COM | 374163103 |
| ELVN | ENLIVEN THERAPEUTICS INC | 535,092 | $13.67M | 2.2% | $21.53 | +7.6% | COM | 29337E102 |
| ADMA | ADMA BIOLOGICS INC | 664,985 | $13.29M | 2.1% | $15.55 | 0.0% | COM | 000899104 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 947,878 | $13.2M | 2.1% | $14.27 | 0.0% | COM | 23954D109 |
| RGEN | REPLIGEN CORP | 88,714 | $13.2M | 2.1% | $143.39 | 0.0% | COM | 759916109 |
| XENE | XENON PHARMACEUTICALS INC | 325,218 | $12.8M | 2.0% | $35.33 | +14.1% | COM | 98420N105 |
| GKOS | GLAUKOS CORP | 96,097 | $12.52M | 2.0% | $124.44 | 0.0% | COM | 377322102 |
| KRYS | KRYSTAL BIOTECH INC | 67,942 | $12.37M | 2.0% | $110.89 | +73.9% | COM | 501147102 |
| CYTK | CYTOKINETICS INC | 223,147 | $11.78M | 1.9% | $36.21 | +53.9% | COM NEW | 23282W605 |
| RCKT | ROCKET PHARMACEUTICALS INC | 621,306 | $11.48M | 1.8% | $24.92 | -17.8% | COM | 77313F106 |
| BBIO | BRIDGEBIO PHARMA INC | 399,781 | $10.18M | 1.6% | $26.25 | 0.0% | COM | 10806X102 |
| RLAY | RELAY THERAPEUTICS INC | 1,226,354 | $8.683M | 1.4% | $7.47 | 0.0% | COM | 75943R102 |
| SPRY | ARS PHARMACEUTICALS INC | 593,291 | $8.603M | 1.4% | $11.89 | 0.0% | COM | 82835W108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 355,000 | $4.111M | 0.7% | $13.33 | -5.7% | COM | 483497103 |